Noam E. Kopmar

865 total citations
12 papers, 552 citations indexed

About

Noam E. Kopmar is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Molecular Biology. According to data from OpenAlex, Noam E. Kopmar has authored 12 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Noam E. Kopmar's work include Acute Lymphoblastic Leukemia research (6 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Noam E. Kopmar is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Noam E. Kopmar collaborates with scholars based in United States, Australia and Lithuania. Noam E. Kopmar's co-authors include Davide Ruggero, Cristian Bellodi, Sunnie R. Thompson, Dori M. Landry, Sharmishtha Musalgaonkar, Afshan Dean, Arturas Meškauskas, Jonathan D. Dinman, Rachel O. Niederer and Ryan D. Cassaday and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Noam E. Kopmar

9 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noam E. Kopmar United States	6	492	138	80	43	32	12	552
Wentao Zeng China	10	332 0.7×	252 1.8×	59 0.7×	26 0.6×	4 0.1×	16	467
Giorgia Montano Sweden	13	319 0.6×	43 0.3×	49 0.6×	16 0.4×	35 1.1×	17	435
Kazuto Sugimura Japan	8	498 1.0×	95 0.7×	180 2.3×	42 1.0×	6 0.2×	10	571
Mira Kassouf United Kingdom	8	453 0.9×	36 0.3×	19 0.2×	41 1.0×	89 2.8×	14	542
Jon Burdach Australia	11	455 0.9×	122 0.9×	13 0.2×	47 1.1×	79 2.5×	14	576
Yuichiro Semba Japan	12	203 0.4×	29 0.2×	30 0.4×	12 0.3×	60 1.9×	35	305
Jin Woo Park South Korea	11	357 0.7×	61 0.4×	52 0.7×	9 0.2×	27 0.8×	19	406
Bruno Lemieux Canada	9	371 0.8×	45 0.3×	62 0.8×	120 2.8×	12 0.4×	14	449
Arianna Mangiavacchi Saudi Arabia	7	417 0.8×	285 2.1×	19 0.2×	21 0.5×	38 1.2×	8	476
Mya Steadman United States	5	212 0.4×	122 0.9×	27 0.3×	35 0.8×	66 2.1×	7	334

Countries citing papers authored by Noam E. Kopmar

Since Specialization

Citations

This map shows the geographic impact of Noam E. Kopmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam E. Kopmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam E. Kopmar more than expected).

Fields of papers citing papers by Noam E. Kopmar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam E. Kopmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam E. Kopmar. The network helps show where Noam E. Kopmar may publish in the future.

Co-authorship network of co-authors of Noam E. Kopmar

This figure shows the co-authorship network connecting the top 25 collaborators of Noam E. Kopmar. A scholar is included among the top collaborators of Noam E. Kopmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noam E. Kopmar. Noam E. Kopmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gauthier, Jordan, Emily C. Liang, Jennifer J. Huang, et al.. (2025). Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL. Blood Advances. 9(8). 1861–1872.

Kopmar, Noam E. & Ryan D. Cassaday. (2024). Clinical Insights on Brexucabtagene Autoleucel for the Treatment of Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Cancer Management and Research. Volume 16. 1587–1596. 5 indexed citations

Kopmar, Noam E., Henry H. Le, Ted Gooley, et al.. (2024). Extended Follow-up of Dose-Adjusted EPOCH (DA-EPOCH) Plus Inotuzumab Ozogamicin (InO) in Adults with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Safe and Effective Salvage Therapy. Blood. 144(Supplement 1). 4209–4209.

Kopmar, Noam E., Ted Gooley, Sindhu Cherian, et al.. (2024). Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL. JAMA Oncology. 10(7). 961–961. 4 indexed citations

Roloff, Gregory W., Rawan Faramand, Ibrahim Aldoss, et al.. (2023). Outcomes following brexucabtagene autoleucel administered as an FDA-approved therapy for adults with relapsed/refractory B-ALL.. Journal of Clinical Oncology. 41(16_suppl). 7001–7001. 8 indexed citations

Kopmar, Noam E., Ted Gooley, Sindhu Cherian, et al.. (2023). A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory (R/R) B lymphoblastic leukemia/lymphoma (B-ALL).. Journal of Clinical Oncology. 41(16_suppl). 7007–7007.

Kopmar, Noam E. & Ryan D. Cassaday. (2022). How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia. Blood. 141(12). 1379–1388. 24 indexed citations

Kopmar, Noam E. & Elihu H. Estey. (2019). New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.. PubMed. 17(10). 569–575. 8 indexed citations

Boonyaratanakornkit, Jim, Robert J. Cybulski, Noam E. Kopmar, et al.. (2017). Getting to the Heart of the Matter: A 20-Year-Old Man With Fever, Rash, and Chest Pain. Open Forum Infectious Diseases. 5(1). ofx272–ofx272. 1 indexed citations

10.

Bellodi, Cristian, Mary McMahon, Adrian Contreras, et al.. (2013). H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation. Cell Reports. 3(5). 1493–1502. 111 indexed citations

11.

Bellodi, Cristian, Dori M. Landry, Rachel O. Niederer, et al.. (2011). rRNA Pseudouridylation Defects Affect Ribosomal Ligand Binding and Translational Fidelity from Yeast to Human Cells. Molecular Cell. 44(4). 660–666. 251 indexed citations

12.

Bellodi, Cristian, Noam E. Kopmar, & Davide Ruggero. (2010). Deregulation of oncogene‐induced senescence and p53 translational control in X‐linked dyskeratosis congenita. The EMBO Journal. 29(11). 1865–1876. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact